Real-life lithium use in people with bipolar disorder
Official title: Real-world Lithium Intake Measured by a Pillbox: A Clinical Study to Test Real-world Compliance With Lithium Treatment
Run by University of Aarhus · NCT07167563 · Data updated 2026-11-12
This project will track daily lithium-taking patterns in adults with bipolar disorder using a smart pill box that timestamps removals plus weekly phone check-ins.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Aarhus) |
| Status | Recruiting |
| Started | July 5, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | July 15, 2026 |
| Registry record updated | September 11, 2025 |
| Trial ID | NCT07167563 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) diagnosed with bipolar disorder who are being treated with lithium and followed at the Bipolar Disorder outpatient clinic, and who can give informed consent.
✕Probably not a fit
People not taking lithium, those in forensic or coercive care, or patients judged unable by their clinician to participate are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project follows adult outpatients with bipolar disorder who are treated with lithium at the Aarhus University Hospital clinic. Participants use a pill box that records the time each lithium tablet is removed as a proxy for actual intake and receive a weekly phone call to report additional details about dosing. No changes to clinical treatment are made; data are collected during routine care to describe adherence patterns and timing of doses. The findings will be used to understand real-world dosing behavior and how it relates to guideline-recommended timing for lithium blood sampling.
Why it matters
Potential benefit: If successful, the results could help clinicians better time blood tests and design adherence supports to keep lithium levels safer and more effective.
How similar studies have gone: Electronic pill-box adherence monitoring has provided useful data in other psychiatric and chronic disease groups, though using it specifically to study lithium timing is relatively uncommon.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years 2. Diagnosed with bipolar disorder (ICD-10: F30-31) 3. Followed at the bipolar disorder outpatient clinic at AUHP 4. Treated with lithium (ATC-code: N05AN01) 5. Able to give informed oral and written consent. Exclusion Criteria: 1. Any coercive measure in the study period including patients in forensic psychiatry. 2. In a clinical condition where the treating clinician evaluates that the patient is not able to attend the research study.
Where it's running
-
Clinic for Bipolar Disorder, Aarhus University Hospital Psychiatry
Aarhus, Denmark Recruiting
Study contacts
- Study coordinator: Ole Köhler-Forsberg, MD, PhD, Assoc. Professor
- Email: karkoe@rm.dk
- Phone: +4578451770
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
Customized brain stimulation to help mood in bipolar disorder
This study tests whether personalized, non-invasive brain stimulation with rTMS can help people with bipolar depression see if their mood shifts toward euthymia.
-
Pramipexole adds on to mood stabilizers for bipolar depression
This trial tests whether adding pramipexole to standard mood-stabilizing treatment helps reduce anhedonia in adults with bipolar depression compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.